title: Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
abstract: Neuroendocrine tumor cells frequently overexpress somatostatin receptors at their cell surfaces. To evaluate the possibility of using the somatostatin analog 111In-DTPA-D-Phe1-octreotide for radiation therapy, we studied the binding and subsequent internalization of 111In into three types of cultured human neuroendocrine tumor cells.
  
  
  METHODS
  Primary cultures of gastric carcinoid, midgut carcinoid and glucagonoma cells were incubated with 111In-DTPA-D-Phe1-octreotide and cell-surface bound, internalized and released 111In activity was measured. Electron microscopic autoradiography was also performed.
  
  
  RESULTS
  All three cell types specifically (80%-95%) bound 111In-DTPA-D-Phe1-octreotide and internalized 111In. After 1 hr pulse incubation with 111In-DTPA-D-Phe1-octreotide, there was an initial decrease in intracellular 111In to about 50% during the subsequent 6-hr incubation. Almost no further release was observed during the remaining 18-42 hr studied. Autoradiography showed that the internalized 111In was found in the cytoplasm and nucleus in the midgut carcinoid cells.
  
  
  CONCLUSIONS
  Indium-111 DTPA-D-Phe1-octreotide might be useful for radiation therapy of patients with surgically incurable tumors having high somatostatin receptor densities.
authors.affiliation: Department of Radiation Physics, Göteborg University, Sahlgrenska University Hospital, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Andersson
authors.forename: E
authors.initials: E
authors.lastname: Forssell-Aronsson
authors.forename: V
authors.initials: V
authors.lastname: Johanson
authors.forename: B
authors.initials: B
authors.lastname: Wängberg
authors.forename: O
authors.initials: O
authors.lastname: Nilsson
authors.forename: M
authors.initials: M
authors.lastname: Fjälling
authors.forename: H
authors.initials: H
authors.lastname: Ahlman
mesh_terms: D001345:Autoradiography; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging* / Q000378:metabolism; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism; D005935:Glucagonoma / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D007205:Indium Radioisotopes / Q000493:pharmacokinetics; D015282:Octreotide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D014407:Tumor Cells, Cultured / Q000000981:diagnostic imaging / Q000378:metabolism
chemical_list: D007205:Indium Radioisotopes; C071632:SDZ 215-811; D004369:Pentetic Acid; D015282:Octreotide